RIONDINO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 16.311
AS - Asia 2.147
EU - Europa 1.731
SA - Sud America 323
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 33
OC - Oceania 4
Totale 20.814
Nazione #
US - Stati Uniti d'America 16.161
SG - Singapore 1.016
IT - Italia 419
CN - Cina 394
BR - Brasile 266
RU - Federazione Russa 230
HK - Hong Kong 181
UA - Ucraina 173
IE - Irlanda 165
DE - Germania 162
VN - Vietnam 160
FR - Francia 158
GB - Regno Unito 113
PL - Polonia 113
BD - Bangladesh 99
FI - Finlandia 76
KR - Corea 68
CA - Canada 62
JP - Giappone 62
IN - India 55
NL - Olanda 37
ID - Indonesia 23
AR - Argentina 18
ES - Italia 17
MX - Messico 16
SE - Svezia 14
AT - Austria 13
EC - Ecuador 13
CR - Costa Rica 12
TR - Turchia 12
CO - Colombia 11
SA - Arabia Saudita 11
PK - Pakistan 10
CW - ???statistics.table.value.countryCode.CW??? 9
EG - Egitto 9
GT - Guatemala 9
HN - Honduras 9
IQ - Iraq 9
JM - Giamaica 9
MA - Marocco 9
MY - Malesia 9
PH - Filippine 9
BE - Belgio 8
NI - Nicaragua 7
SV - El Salvador 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
EU - Europa 5
GP - Guadalupe 5
TT - Trinidad e Tobago 5
AL - Albania 4
NP - Nepal 4
PR - Porto Rico 4
PT - Portogallo 4
ZA - Sudafrica 4
AU - Australia 3
LT - Lituania 3
PY - Paraguay 3
TH - Thailandia 3
UZ - Uzbekistan 3
VE - Venezuela 3
BB - Barbados 2
CG - Congo 2
DK - Danimarca 2
GA - Gabon 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BZ - Belize 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 20.564
Città #
Woodbridge 4.030
Wilmington 3.611
Houston 3.483
Singapore 578
Ashburn 498
Fairfield 439
San Jose 353
Chandler 287
Ann Arbor 275
Seattle 216
Cambridge 200
Hong Kong 176
Beijing 158
Council Bluffs 154
Dublin 143
Jacksonville 143
New York 131
Rome 113
Kraków 105
Medford 103
Santa Clara 101
The Dalles 92
Los Angeles 84
Dallas 70
Dearborn 61
Tokyo 60
Buffalo 57
San Diego 55
Ho Chi Minh City 52
Lawrence 48
Lauterbourg 45
Menlo Park 35
Hanoi 33
Denver 32
Milan 32
Moscow 31
Orem 31
North Bergen 29
Helsinki 25
Chicago 24
Zhengzhou 24
São Paulo 23
Engelhard 20
Nuremberg 20
London 19
Jakarta 16
Chennai 15
Salt Lake City 15
Montreal 14
Lappeenranta 13
Boardman 12
Frankfurt am Main 12
Manchester 12
Brooklyn 11
Detroit 11
Nanjing 11
Redondo Beach 11
Toronto 11
Brasília 10
Mumbai 10
Turin 10
Washington 10
Atlanta 9
Columbus 9
Miami 9
Munich 9
Naples 9
Newark 9
Quito 9
San Francisco 9
Willemstad 9
Boston 8
Brussels 8
Creede 8
Da Nang 8
Phoenix 8
San José 8
Shanghai 8
Verona 8
Ankara 7
Fort Worth 7
Guangzhou 7
Guatemala City 7
Managua 7
Norwalk 7
Rio de Janeiro 7
San Pedro Sula 7
San Salvador 7
Warsaw 7
Amsterdam 6
Brno 6
Kunming 6
Roubaix 6
Stockholm 6
Tampa 6
Belo Horizonte 5
Calgary 5
Charlotte 5
Cleveland 5
Falls Church 5
Totale 16.779
Nome #
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 510
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 504
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 482
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 481
Biological and predictive role of ERCC1 polymorphisms in cancer 480
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 479
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 475
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 474
Clinical models and biochemical predictors of VTE in lung cancer 472
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 469
Prognostic value of glycated hemoglobin in colorectal cancer 469
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 468
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 466
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 465
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 464
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 460
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 459
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 454
Determinants of homocysteine levels in colorectal and breast cancer patients 446
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 445
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 441
VEGF and VTE risk in cancer patients-letter 429
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 428
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 427
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 423
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 416
Impact of VEGF gene polymorphisms in elderly cancer patients: Clinical outcome and toxicity 415
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy 414
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 413
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 408
Prognostic significance of serum adipokine levels in colorectal cancer patients 401
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence 395
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 394
Insulin resistance as a predictor of venous thromboembolism in breast cancer 386
Breast Cancer Prognosis Using a Machine Learning Approach 386
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 359
SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens 339
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 339
Precision medicine in the ageing world: The role of biospecimen sciences 315
Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models 254
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 172
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 153
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 151
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 149
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 148
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 143
Irinotecan or oxaliplatin: which is the first move for the mate? 143
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients 143
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 142
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 135
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 131
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 128
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 127
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 122
Drug recommendation ranking for personalized medicine using outcomes of retrospective cancer patients 112
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 110
Evaluating Explainable Machine Learning Models for Clinicians 109
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 106
Gender differences in cancer-associated venous thromboembolism 102
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 98
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 96
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 96
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 96
Biospecimen Digital Twins: Moving from a "High Quality" to a "Fit-for-Purpose" Concept in the Era of Omics Sciences 94
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 91
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials 88
Obesity and common pathways of cancer and cardiovascular disease 79
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production 71
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities 65
Obesity-driven inflammation and colorectal cancer 60
Factor seven activating protease activity levels in women with recurrent pregnancy loss 56
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology 47
Clusters of Anthropometric Features in Colorectal Cancer Patients with Synchronous Metastases and Their Association with Overall Survival and RAS Mutation 47
Totale 20.814
Categoria #
all - tutte 55.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022541 0 0 0 10 19 30 56 107 36 128 32 123
2022/2023713 71 63 11 82 95 160 48 66 56 7 29 25
2023/2024334 34 10 23 23 23 94 42 12 8 6 6 53
2024/20251.603 44 361 146 108 43 88 134 87 185 188 138 81
2025/20262.857 193 126 367 198 267 90 357 317 337 230 262 113
2026/20271.241 162 177 522 380 0 0 0 0 0 0 0 0
Totale 20.814